Intravenous dosing of tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis: results from an open-label phase 1 clinical trial

Overview of attention for article published in Pediatric Rheumatology, August 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source

twitter: 1 X user

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 57 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 2,053 followers.

Intravenous dosing of tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis: results from an open-label phase 1 clinical trial https://t.co/C3YgxhgH5c

24 Aug 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.